The southern Africa country has the world’s highest prevalence of HIV but the amount of lenacapavir reaching it is too small to reach all those at risk ...

Eswatini, the country with the highest HIV prevalence in the world, is one of the first places to distribute lenacapavir, an ...

Pharmaceutical company Gilead Sciences has refused to directly sell its HIV prevention drug to Doctors Without Borders.

Global health is evolving rapidly, with breakthroughs turning into medicine. The latest advancement in viral research is ...

The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of ...

Compared to daily oral pre-exposure prophylaxis (PrEP), lenacapavir reduces the number of new HIV infections by many more; causes slightly fewer serious unwanted effects; and results in little to no ...

Jeffrey Okoro, of CFK Africa, tells Rachel Hagan that the drug lenacapavir can be transformative, but Kenya’s rollout is not ...

According to UNAIDS, in 2024, about 40.8 million people around the world were living with the human immunodeficiency virus (HIV) — a virus that can lead to acquired immunodeficiency syndrome (AIDS) if ...

The director-general of the National Agency for the Control of AIDS (NACA), Temitope Ilori, has clarified that the newly ...

Medicines charity group MSF (Medecins Sans Frontieres/Doctors Without Borders) reported that US drugmaker Gilead Sciences has ...

The fight against HIV/AIDS in Nigeria got a boost with the introduction of twice-yearly injectable Lenacapavir (LEN) in eight states. The rollout, which will begin in Anambra, Ebonyi, Gombe, Kwara, ...